购买一盒雷帕鸣多少钱

(Sirolimus) is a new type of immunosuppressant developed by Wyeth Company of the United States. Different from tacrolimus, which is a structural homologue, although it acts on the same receptor, its mechanism of action is different. It mainly inhibits the body's immune function by affecting unique cell signaling pathways. In September 1999, the drug was approved by the US FDA and officially launched on the market. It is mainly used to prevent and treat rejection of kidney, liver and other transplants. It is especially suitable for patients with renal dysfunction, tremor and hypertension. The drug has low oral bioavailability, large inter-individual pharmacokinetic (PK) differences, and is a substrate of CYP3A and P glycoprotein (PgP), which can cause drug-drug interactions with a variety of drugs.

Drug prices have always been a concern of patients, so how much does it cost to buy a box of Rapamin?

Due to the different specifications of Leipaming, there are certain differences in its domestic pricing. In China, it usually costs 143$ to 2739$ for patients to purchase a box of Rapamin, while abroad, it costs about 1800$ for patients to purchase a box of the drug. Patients can choose to purchase according to their actual needs. Since the price is not fixed due to exchange rate fluctuations, patients who want to know more can consult some professional overseas medical service organizations in China, such as Medical Companion Travel.

After purchasing the medicine, patients must strictly follow the instructions or doctor's instructions to take the medicine. (Sirolimus Tablets) It is recommended to be used in combination with cyclosporine and corticosteroids. The medication is taken orally once a day. Patients should start taking it as soon as possible after receiving a kidney transplant. The recommended loading dose for kidney transplant patients is 6 mg and the maintenance dose is 2 mg/day. Although the loading dose of 15 mg and the maintenance dose of 5 mg/day used in clinical trials are safe and effective, the therapeutic benefits of doses above 2 mg are unclear for kidney transplant patients.

Recommended hot articles: /newsDetail/72773.html